Effects of proinflammatory cytokines on lacrimal gland myoepithelial cells contraction.
Contractile proteins
Inflammation
Interleukin-1β
Lacrimal gland
Myoepithelial cells
Journal
Frontiers in ophthalmology
ISSN: 2674-0826
Titre abrégé: Front Ophthalmol (Lausanne)
Pays: Switzerland
ID NLM: 9918419176106676
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
ppublish
Résumé
In the lacrimal gland, myoepithelial cells (MEC) express muscle contractile proteins such as alpha smooth muscle actin (SMA) and calponin and therefore can contract to help expel lacrimal fluid. In a previous study, we demonstrated that lacrimal gland MEC express the oxytocin receptor (OXTR) and they contract under oxytocin (OXT) stimulation. Using NOD and MRL/lpr mice (animal models of Sjogren's syndrome), we reported a decrease in SMA and calponin protein levels plus a decline in acini contraction after stimulation with OXT. It is known that proinflammatory cytokines, such as interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α) or interferon gamma (IFN-γ), can affect OXTR expression and signaling capacity and inhibit MEC contraction. The aim of the current study was to investigate if proinflammatory cytokines are implicated in the loss of MEC contractile ability. Thus, lacrimal gland MEC from a SMA-GFP transgenic mouse were treated with IL-1β (10 ng/ml) for a total of 7 days. At days 0, 2, 4 and 7, GFP intensity, cell size/area, contractile proteins amounts and MEC contraction were assessed. At day 0, control and treated cells showed no differences in GFP intensity and cell size. GFP intensity started to decrease in treated MEC at day 2 (20%; p=0.02), continuing after day 4 (25%; p=0.007) and 7 (30%; p=0.0001). Mean cell area was also reduced at day 2 (34%; p=0.0005), and after 4 (51%; p<0.0001) and 7 days (30%; p=0.0015). The contraction assay at day 2 showed a 70% decrease of contraction in treated MEC (p<0.0001), 73% (p<0.0001) at day 4 and 82% (p=0.0015) at day 7 when compared to control. Levels of contractile proteins were measured on day 7 showing a decrease in SMA and calponin amount in treated MEC compared with the control group (around 30%; p=0.0016 and p=0.0206; respectively). Similar results were observed when TNF-α and IFN-γ were added along with IL-1β. Taken together the present data and those from our previous studies with Sjogren's syndrome mouse models, they strongly suggest that proinflammatory cytokines affect lacrimal gland MEC contractile ability that may account for the reduced tear secretion associated with Sjogren's syndrome dry eye disease.
Identifiants
pubmed: 36147586
doi: 10.3389/fopht.2022.873486
pmc: PMC9491489
mid: NIHMS1825647
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NEI NIH HHS
ID : R01 EY029870
Pays : United States
Références
Invest Ophthalmol Vis Sci. 2002 May;43(5):1429-36
pubmed: 11980857
Am J Obstet Gynecol. 1999 Aug;181(2):359-66
pubmed: 10454683
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):662-8
pubmed: 22199370
J Endocrinol. 1997 Jul;154(1):7-18
pubmed: 9246933
FASEB J. 2004 Jan;18(1):39-51
pubmed: 14718385
Nature. 2002 Jan 10;415(6868):206-12
pubmed: 11805844
Biol Cell. 1996;86(2-3):175-81
pubmed: 8893507
Regul Pept. 2007 Aug 16;142(3):78-85
pubmed: 17428554
Am J Reprod Immunol. 2000 Feb;43(2):85-91
pubmed: 10735599
Biochim Biophys Acta. 1995 Apr 6;1266(1):31-44
pubmed: 7718619
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):25
pubmed: 34812841
Histol Histopathol. 1995 Oct;10(4):821-7
pubmed: 8574002
Mol Hum Reprod. 2006 Oct;12(10):619-24
pubmed: 16888077
Stem Cells. 2006 Jan;24(1):13-22
pubmed: 16099999
Curr Mol Biol Rep. 2015 Sep 1;1(3):115-123
pubmed: 26688786
Am J Obstet Gynecol. 1994 Dec;171(6):1627-34
pubmed: 7802080
Arthritis Res Ther. 2011 Jul 06;13(4):227
pubmed: 21745420
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5218-28
pubmed: 26244298
Life Sci. 1995;57(24):2253-61
pubmed: 7475979
Science. 1990 Jun 22;248(4962):1547-50
pubmed: 2163110
J Soc Gynecol Investig. 2002 Jan-Feb;9(1):15-21
pubmed: 11839503
Endocrinology. 2001 Apr;142(4):1380-5
pubmed: 11250916
J Physiol. 1968 May;196(2):381-96
pubmed: 5652882
Nat Rev Rheumatol. 2018 Mar;14(3):133-145
pubmed: 29416129
Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R580-90
pubmed: 15563579
Invest Ophthalmol Vis Sci. 2011 Dec 16;52(13):9503-15
pubmed: 22039237
J Am Soc Nephrol. 2006 Jul;17(7):1807-19
pubmed: 16738015
Oral Dis. 2009 Nov;15(8):519-26
pubmed: 19519622
Sci Rep. 2018 Jul 2;8(1):9919
pubmed: 29967327
Int J Mol Sci. 2018 Nov 10;19(11):
pubmed: 30423813
J Clin Invest. 2004 Jan;113(1):115-23
pubmed: 14702115
Am J Anat. 1971 Oct;132(2):133-45
pubmed: 5112466